Stay updated on Biogen Press Releases
Sign up to get notified when there's something new on the Biogen Press Releases page.

Latest updates to the Biogen Press Releases page
- Check8 days agoChange DetectedA new press release titled 'Biogen Announces Board Chair Transition' dated February 11, 2026 has been added to the News section.SummaryDifference0.7%

- Check15 days agoChange DetectedThree new News releases were added: Nature Medicine publishes the DEVOTE nusinersen SMA results (Feb 4, 2026); Biogen Reports Fourth Quarter and Full Year 2025 Results (Feb 6, 2026); and LEQEMBI subcutaneous formulation designated for priority review in China (Feb 8, 2026).SummaryDifference2%

- Check22 days agoChange DetectedA new Biogen news item appears on the page: 'Biogen’s Litifilimab Receives FDA Breakthrough Therapy Designation for Cutaneous Lupus Erythematosus, a Disease With No Targeted Treatment Options' dated January 28, 2026.SummaryDifference0.8%

- Check29 days agoChange DetectedA new news release item was added to the News Releases page announcing FDA Accepts LEQEMBI® IQLIK™ (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer’s Disease under Priority Review (January 25, 2026).SummaryDifference0.8%

- Check43 days agoChange DetectedAdded two Biogen News releases: the Q4 and full-year 2025 financial results announcement (February 6, 2026) and the European Commission approval of a high-dose Spinraza regimen for SMA (January 12, 2026).SummaryDifference2%

- Check50 days agoChange DetectedNew 2026 news entries were added, including Biogen to Present at the 44th Annual J.P. Morgan Healthcare Conference and the LEQEMBI submission accepted in China, along with a 2026 copyright line, while older 2025 items were removed.SummaryDifference8%

Stay in the know with updates to Biogen Press Releases
Enter your email address, and we'll notify you when there's something new on the Biogen Press Releases page.